VABOMERE

Melinta Therapeutics, LLC🇺🇸 United States

FDA Page

Effective Date: Oct 19, 2023
Approval ID: e237fd0f-3050-42a3-b43e-b6fb4824e93d
Products: 1 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VABOMERE safely and effectively. See full prescribing information for VABOMERE. VABOMERE (meropenem and vaborbactam) for injection, for intravenous use Initial U.S. Approval: 2017

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.